|
PROGRAM
Last updated
10 October 2008
|
Saturday,
13 September 2008 |
|
18:00 to 20:00 |
Registration |
|
|
|
|
|
|
Sunday, 14
September 2008 |
|
08:00 |
Registration |
|
|
08:30 |
Welcome |
|
|
|
|
Welcome
Arend Heerschap, Ph.D., Radboud University, Nijmegen, The
Netherlands |
|
|
|
Patrick J. Cozzone, Ph.D., Centre de Résonance
Magnétique Biologique et Médicale, Marseille, France |
|
|
|
|
|
09:00 |
|
Understanding Lipid in the Tumor Cell
Kristine Glunde, Ph.D., Johns Hopkins University,
Baltimore, MD, USA |
|
|
|
|
|
|
Proffered Papers |
|
09:45 |
|
Assessment of local differences in
phosphocholine and phosphoethanolamine content in human
brain tumours by 31P MRSI using 1H - 31P polarisation
transfer. - not available
Jannie Wijnen, M.Sc., Department of Radiology, Radboud
University Medical Centre Nijmegen |
|
|
|
|
|
10:00 |
|
MRS and Genomic Studies on Choline
Metabolism in Ovarian Cancer: from Cells to Patients
Egidio Iorio, Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, Rome |
|
|
|
|
|
10:15 |
|
Cervix Metabolite Changes Associated
with Cancer Measured with 1H CSI in vivo
Geoffrey Payne, Cancer Research UK Clinical Magnetic
Resonance Research Group, Institute of Cancer Research and
Royal Marsden NHS Foundation Trust, Sutton, UK |
|
|
|
|
|
10:30 |
Coffee/ Tea Break |
|
|
Poster Session |
|
|
|
|
|
12:30 |
Lunch |
|
|
|
|
|
|
14:00 |
|
The Tumor Microenvironment - not available
Jacques Pouyssegur, Ph.D., Institute of Signalling, Dev.
Biology and Cancer Research, Nice France |
|
|
|
|
|
|
Proffered Papers |
|
14:45 |
|
The First Sodium and Diffusion MRI
during Chemotherapy of Rodent Glioma at 21T
Victor Schepkin, Ph.D., National High Magnetic Field Lab, FSU,
Tallahassee, FL, USA |
|
|
|
|
|
15:00 |
|
Imaging Phospholipase Activity in vivo
James Delikatny, Laboratory of Molecular Imaging, Department of
Radiology, University of Pennsylvania, Philadelphia, PA, USA |
|
|
|
|
|
15:15 |
|
CSI-monitored effects of acute
hyperglycemia and moderate hypothermia in a glioma mouse
model
Rui Simões, Bs.Hon., Bioquímica i Biologia Molecular, Universitat
Autònoma de Barcelona, Spain |
|
|
|
|
|
15:30 |
Coffee/Tea Break |
|
|
|
|
|
16:00 |
|
New MR Insights into Invasion and Metastasis
Paula Foster, Ph.D., Robarts Research Institute, London,
UK |
|
|
|
|
|
|
Proffered Papers |
|
16:45 |
|
Breast and prostate tumor detection
using LHRH receptor targeted contrast agent in iMQC and
Hyperpolarized 3He experiments
Rosa Branca, Ph.D., Duke University, Durham NC, USA |
|
|
|
|
|
17:00 |
|
Estimating the growth process of
gliomas using physiological models
Björn Menze, Ph.D., Harvard Medical School, Boston, MA,
USA |
|
|
|
|
|
17:15 |
|
The response of orthotopic prostate
tumours to a putative PLCgamma inhibitor in vivo
Jake Burrell, B.Sc., The Institute of Cancer Research,
Sutton, Surrey, UK |
|
|
|
|
|
17:30 |
Break |
|
|
|
|
|
|
17:45 |
|
Controversy: Targeted Contrast Media for Molecular MR
Imaging in Cancer – a Valuable Toolset or a Research
Cul-de-sac?
Silvio Aime, Ph.D., University of Toronto, Toronto,
Canada |
|
|
|
Claire
Corot, Ph.D., Guerbet Research, Cedex, France |
|
|
|
|
|
20:00 |
Dinner |
|
|
|
|
|
|
Monday, 15
September 2008 |
|
08:00 |
Registration |
|
|
|
|
|
|
|
William G. Negendank Memorial Lecture |
|
08:30 |
|
A Clinical Role for MRS in Cancer Diagnosis and Management
John Griffiths, M.B.B.S., D.Phil., Cancer Research,
Cambridge, UK |
|
|
|
|
|
09:30 |
|
13C MR in
Cancer – Hyperpolarised and Conventional
Kevin Brindle, D.Phil., University of Cambridge,
Cambridge, UK |
|
|
|
|
|
|
Proffered Papers |
|
10:15 |
|
Monitoring metabolically active lactate
using hyperpolarized
13C MR spectroscopic imaging in a human Glioblastoma Xenograft
Ilwoo Park,
Surbeck Laboratory of Advanced Imaging, Department of
Radiology and Biomedical Imaging,
University of California, San Francisco, CA, USA |
|
|
|
|
|
10:30 |
|
Combined DCE-MRI and hyperpolarized 13C MRSI indicate
anassociation between vascular and metabolic effects of
imatinib in a prostate cancer bone metastasis model
Hagit Dafni, Ph.D., Department of Radiology and
Biomedical Imaging, University of California, San Francisco,
CA, USA |
|
|
|
|
|
10:45 |
|
Hyperpolarized 13C MRS detection of reduced lactate
production following PI3K inhibition
Christopher Ward, B.A., Department of Radiology and
Biomedical Imaging, University of California, San Francisco,
CA, USA |
|
|
|
|
|
11:00 |
Coffee/Tea
Break |
|
|
|
|
|
11:30 |
|
Newly Emerging Cancer MR Biomarkers – From Discovery to
Evaluation in Man
Zaver Bhujwalla, Ph.D., Johns Hopkins University,
Baltimore, MD, USA |
|
|
|
|
|
|
Proffered Papers |
|
12:15 |
|
Ultra-High Field 1H and 23Na MRI of primary
brain tumors: initial experience
Fernando Boada, Ph.D., Department of Radiology,
University of Pittsburg Medical Center, Pittsburgh, PA, USA
|
|
|
|
|
|
12:30 |
|
Robust estimation of vessel size index from
magnitude MRI data
Simon Walker-Samuel, Ph.D., Institute of Cancer Research,
Sutton, Surrey, UK |
|
|
|
|
|
12:45 |
|
Properties evaluation of a new MRI contrast
agent based on Gd -loaded nano particles coated with nano materials for
cell tracking - not available
Riyahi-Alam Nader, Tehran University of Medical Sciences
(TUMS), Medical Physics & Biomedical Engineering Department,
Tehran, Iran |
|
|
|
|
|
13:00 |
Lunch |
|
|
|
|
|
|
14:00 |
|
|
|
|
|
|
|
|
Proffered Papers |
|
14:45 |
|
MRI guided anti-tumor therapy with
liposomal prednisolone phosphate
Ewelina Kluza, M.Sc., Eindhoven University of Technology,
Department of Biomedical Engineering, Biomedical NMR,
Eindhoven, The Netherlands |
|
|
|
|
|
15:00 |
|
Magnetic resonance imaging
characterization of a murine model of radiation necrosis
Sarah Jost, M.D., Washington University, St. Louis, MO,
USA |
|
|
|
|
|
15:15 |
|
1H MRSI detection of elevated total
creatine in brain cancer:
a cautionary tale
Dikoma Shungu, Ph.D., Department of Radiology, Weill
Cornell Medical College, New York, NY, USA |
|
|
|
|
|
15:30 |
Coffee/Tea Break |
|
|
|
|
|
16:00 |
|
Whole Body DWI Screening
Michael Jacobs, Ph.D., Johns Hopkins University,
Baltimore, MD, USA |
|
|
|
|
|
19:00 |
Dinner |
|
|
|
|
|
|
Tuesday, 16
September 2008 |
|
08:00 |
Registration |
|
|
|
|
|
|
08:30 |
|
Imaging and Cancer Stem Cells
Rolf Bjerkvig, Ph.D., University of Bergen, Bergen,
Norway |
|
|
|
|
|
09:15 |
Coffee/Tea Break |
|
|
|
|
|
09:45 |
|
Clinical Trials and Routine Clinical Use: How to
Present the MR Information So Clinicians Can Make Best Use
of It
Sarah Nelson, Ph.D., University of California San
Francisco, San Francisco, CA, USA |
|
|
|
|
|
|
Proffered Papers |
|
10:30 |
|
Multiparametric MR exam (MRI/MRSI/DTI/DCE)
using 3T without endorectal coil for clinical detection of
prostate cancer: correlation with histopathology
Kirsten Selnæs, Department of Circulation and Medical
Imaging, NTNU, Trondheim, Norway |
|
|
|
|
|
10:45 |
|
Integration of Diffusion Weighted
Imaging and fMRI to identify differential fiber loss in
pre-surgical planning
Fernando Boada, Ph.D., Department of Radiology University
of Pittsburgh Medical Center, Pittsburg, PA, USA |
|
|
|
|
|
11:00 |
|
Differentiating tumor vs.
pseudotumoural disease vs. normal brain with SV 1H-MRS
Julià-Sapé, Ph.D., Centrode Investigación Biomédica en
Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN),
Cerdanyola del Vallès, Barcelona, Spain |
|
|
|
|
|
11:15 |
|
Two radiological advances concerning
prostate cancer: what's hot and what's not?
Tom Scheenen, Ph.D., Department of Radiology, Radboud
University Nijmegen Medical Centre, Nijmegen, The
Netherlands |
|
|
|
|
|
11:30 |
|
Correlation between HRMAS and
histopathology in human glioma biopsies
Franklyn Howe, D.Phil., St George’s, University of
London, London, UK |
|
|
|
|
|
11:45 |
|
Limitations of the modified-Tofts
tracer kinetic model for cancer biomarker studies
David Buckley, Ph.D., Imaging Science & Biomedical
Engineering, University of Manchester, Manchester, UK |
|
|
|
|
|
12:00 |
Adjournment |
|
|
|
|
|
|
The International Society for Magnetic Resonance in Medicine
is accredited
by the Accreditation Council for Continuing Medical
Education to provide
continuing medical education for physicians. |
|
